All News

Codagenix Secures U.S. Patent for Codon-Deoptimized RSV Vaccine Candidates
Ref: PR Newswire
Tags: Press ReleaseCodagenixRespiratory Infections Corporate AffairsCodaVax-RSV
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
Ref: GlobeNewswire
Tags: Press ReleaseAgenus NelumPancreatic Cancer Corporate Affairszalifrelimab NLM-001
OrphoMed Passes First Interim Analysis in Phase 2 Study of Treatment for IBS-D Patients
Ref: Business Wire
Tags: Press ReleaseOrphoMedIrritable Bowel Syndrome Clinical Research (R&D)ORP-101
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication
Ref: GlobeNewswire
Tags: Press ReleaseVaxartCOVID-19 Immunisation Clinical Research (R&D) Medical Affairs
Shionogi and BioAge conclude a license agreement aimed at treating COVID-19
Ref: Shionogi
Tags: Press ReleaseShionogi BioAge LabsCOVID-19 Corporate Affairs LicensingBGE-175
PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer
Ref: Yahoo!Finance
Tags: Press ReleasePharmaDrug Sairiyo Therapeutics Corporate Affairs Mergers & AcquisitionsCepharanthine
Active Biotech’s rights issue heavily oversubscribed
Ref: GlobeNewswire
Tags: Press ReleaseActive Biotech Corporate Affairs
Asieris and Photocure Expand Strategic Partnership to Bladder Cancer Diagnosis and Surgery in Mainland China and Taiwan
Ref: PR Newswire
Tags: Press ReleasePhotocure AsierisBladder Cancer Corporate Affairs LicensingHexvix
First Patient Treated in Phase II Combination Trial of ISA Pharmaceuticals' Lead Immunotherapy ISA101b with Keytruda
Ref: PR Newswire
Tags: Press ReleaseISA Pharmaceuticals Merck & Co.Head and Neck Cancer HPV/Cervical Cancer Clinical Research (R&D)ISA101b Keytruda cisplatin
Dynacure Announces Issuance of U.S. Patent for DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)
Ref: PR Newswire
Tags: Press ReleaseDynacure Ionis Pharmaceuticals Corporate AffairsDyn101